Patent · US Active

Targeting cancer-associated long non-coding RNAs

US11667919B2 · kind B2 · utility

0Cited by

7References

20Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Da Yang · Pittsburgh, US
Zehua Wang · Beijing, CN

Key dates

Filing date	Feb 22, 2019
Grant date	Jun 6, 2023
Priority date	—
Expiry date	Jan 24, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of treating cancer are provided along with nucleic acids and nucleic acid analog sequences of a long-non-coding RNA (lncRNA), and reagents useful for knocking down the lncRNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.